PCOS is a highly heritable (-78%) non-Mendelian disorder. Nevertheless, the common PCOS genetic susceptibility variants mapped by us and by others do not account for the observed heritability of PCOS. This so-called """"""""missing heritability"""""""" has also been observed for other common, highly heritable complex traits such as T2D, height and body mass index (BMI). An explanation for this paradox that is gaining increasing experimental support is that the observed heritability is due to infrequent or rare variants with larger biological effects, in addition to the common variants already identified. Detection of these rare variants is now becoming feasible with the advent of high-throughput Next Generation DNA Sequencing methodologies. It is our overarching hypothesis that rare variants will account for a considerable proportion ofthe missing heritability of PCOS. There will be two Aims: 1) To test the hypothesis that rare genetic variants account for much of the deficit in heritability in women with PCOS. Whole genome sequencing will be performed to identify genetic variants in PCOS families with a proband and three additional affected sisters, in probands from the phenotypic extreme ofthe PCOS population and in women who remain reproductively normal despite morbid obesity. Variants that may have functional consequences that are concordant in the four affected sibs will be genotyped in the remaining family members in these families to identify those that co- segregate with PCOS. These variants, as well as novel/rare variants that are found at elevated frequency in the extreme phenotypes group(s), will be genotyped in the larger set of families with multiple affected sisters, and in the larger case-control population. 2) To test the hypothesis that rare variants identified in Aim 1 are associated with sex-specific metabolic phenotypes in PCOS. Genotype-phenotype associations will be investigated to investigate whether variants mapped with the PCOS reproductive phenotype also have a metabolic phenotype. Rare variants will be investigated in male first-degree relatives to determine if the associated metabolic phenotypes are sex-specific.

Public Health Relevance

PCOS affects 7% of premenopausal women. It is a leading risk factor for type 2 diabetes in affected women and their male as well as female relatives making PCOS a major public health concern. The genetic variants we identify should provide considerable insight into the biological pathways that are disrupted in PCOS. This information should identify novel therapeutic targets and permit better disease prediction.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center (P50)
Project #
5P50HD044405-13
Application #
8721991
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
13
Fiscal Year
2014
Total Cost
$345,817
Indirect Cost
$124,101
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Gorsic, Lidija K; Kosova, Gulum; Werstein, Brian et al. (2017) Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102:2862-2872
Abbott, D H; Rayome, B H; Dumesic, D A et al. (2017) Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod 32:923-936
Sam, Susan; Vellanki, Priyathama; Yalamanchi, Sudha K et al. (2017) Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome. Metabolism 71:125-131
Gibson-Helm, Melanie; Teede, Helena; Dunaif, Andrea et al. (2017) Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102:604-612
Dunaif, Andrea (2016) Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab 101:759-68
Xu, Beibei; Lovre, Dragana; Mauvais-Jarvis, Franck (2016) Effect of selective estrogen receptor modulators on metabolic homeostasis. Biochimie 124:92-97
Torchen, Laura C; Kumar, Ajay; Kalra, Bhanu et al. (2016) Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril 106:50-55
Navarro, Guadalupe; Xu, Weiwei; Jacobson, David A et al. (2016) Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male. Cell Metab 23:837-51
Torchen, Laura C; Idkowiak, Jan; Fogel, Naomi R et al. (2016) Evidence for Increased 5?-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 101:2069-75
Hayes, M Geoffrey; Urbanek, Margrit; Ehrmann, David A et al. (2016) Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 7:10762

Showing the most recent 10 out of 118 publications